Sorted By:

Relevance


PhRMA Statement on FDA User Fees

PhRMA  |  Press Release

The PDUFA VI agreement, along with the BsUFA II and the GDUFA II are needed to ensure the best and brightest minds at FDA are able to keep pace with the rapid advance of medicine.”
https://www.phrma.org/press-release/phrma-statement-on-fda-user-fees

Significant progress fighting cancer: Death rate has dropped 25 percent

PhRMA  |  Blog Post

According to the American Association for Cancer Research’s Cancer Progress Report, the U.S.
http://catalyst.phrma.org/significant-progress-fighting-cancer-death-rate-has-dropped-25

PhRMA Announces Support for Seven-Day Script Limit on Opioid Medicines for Acute Pain

PhRMA  |  Press Release

“Appropriate script limits, when combined with improved prescriber education and better coverage of treatment alternatives, can help ensure proper prescribing and reduce the risk of abuse.
https://www.phrma.org/press-release/phrma-announces-support-for-seven-day-script-limit-on-opioid-medicines-for-acute-pain

Hydeia Loren Broadbent

PhRMA  |  Biography

She succinctly stated, “With all that we know about the virus, it is clear to me that contracting HIV/AIDS today is a choice and we can’t allow anyone the power to make that choice for us!”
https://www.phrma.org/biography/hydeia-loren-broadbent

PhRMA Statement Following Meeting With HHS Secretary Price

PhRMA  |  Press Release

Ubl issued the following statement: “We had a productive meeting with Health and Human Services Secretary Tom Price in which we expressed our commitment to working with the Administration to advance market-based reforms, such as addressing barriers to value-based payment arrangements, enhancing generic competition and ensuring patients benefit from the discounts and rebates negotiated by payers.
https://www.phrma.org

Lupus Foundation of America Event Calls for More Progress for Patients

PhRMA  |  Blog Post

  As Castellani noted during the panel, by working together to develop, evaluate and deliver new medicines, our collective ecosystem will be able to bring cures and treatments to patients suffering from lupus and other chronic diseases faster and in a better way than ever before.
http://catalyst.phrma.org/lupus-foundation-of-america-event-calls-for-more-progress-for-patients

I'm Not Average: Jamie Survives Cancer Despite the Odds

PhRMA  |  Video

When Jamie was diagnosed with Chronic Myelogenous Leukemia (CML), she faced the very real possibility of planning her funeral.
https://www.phrma.org/video/i-m-not-average-jamie-survives-cancer-despite-the-odds

PhRMA Statement on Canada’s Supreme Court Overturning the “Promise” Doctrine

PhRMA  |  Press Release

This policy has hurt Canadian patients and the medical community. 
https://www.phrma.org

PhRMA Statement Regarding Benefits of New Medicines

PhRMA  |  Press Release

“For these and other reasons, our initial reading of this research paper finds its arguments seriously flawed.”
https://www.phrma.org/press-release/phrma-statement-regarding-benefits-of-new-medicines

Clinical Trials Q&A: Examining clinical trial design

PhRMA  |  Blog Post

She is an advisor to pharma sponsors in the design and implementation of patient-directed global programs that leverage data, insights and mobile/digital technology to satisfy patient/caregiver, provider, payer and regulator needs.
http://catalyst.phrma.org/clinical-trials-qa-examining-clinical-trial-design

Medicare Monday: How Part B has evolved over the years

PhRMA  |  Blog Post

It is even updated quarterly to ensure the reimbursement rate keeps pace with other changes in the market.
http://catalyst.phrma.org/how-part-b-has-evolved-over-the-years

Canada’s innovation challenge

PhRMA  |  Blog Post

In fact, a new paper by the Canadian American Business Council (CABC) lays out steps for the Government of Canada to advance its innovation agenda and grow the Canadian economy.
http://catalyst.phrma.org/canadas-innovation-challenge

Ask About Adherence: Discussion on medication adherence as national priority

PhRMA  |  Blog Post

., blood pressure) and harness the power of predictive analytics to identify patients at highest risk for medication-related issues.”
http://catalyst.phrma.org/ask-about-adherence-discussion-on-medication-adherence-as-national-priority

340B: Keeping a Promise to Patients

PhRMA  |  Blog Post

This paper follows an earlier AIR340B analysis that revealed shockingly low levels of charity care provided at 340B hospitals.
http://catalyst.phrma.org/340b-keeping-a-promise-to-patients

Dangers of drug importation: A case of counterfeit cancer drugs

PhRMA  |  Blog Post

In China, a counterfeiter was able to collect empty vials of a cancer medication from a hospital’s trash and refill them with a solution of water and an assortment of chemicals.
http://catalyst.phrma.org/dangers-of-drug-importation-a-case-of-counterfeit-cancer-drugs

PhRMA Supports American Medicine Chest Challenge

PhRMA  |  Press Release

PhRMA recommends that all unused medicines, unless specified otherwise by the Food and Drug Administration, should be mixed with water; sealed in an opaque container safely secure from children, pets, and others; then discarded in household trash to be later incinerated or placed in a government approved solid waste landfill.
https://www.phrma.org/press-release/phrma-supports-american-medicine-chest-challenge

New technologies are accelerating drug development, bringing hope to patients

From Hope To Cures  |  From Our Network

We’ll also help in a later stage, when sirolimus is ready for testing, with tools such as Pathway Studio, which enables the study and visualization of disease mechanisms, gene expression, and proteomics and metabolomics data, to assess CHI’s biological make-up in depth, and then shortlist additional promising potential treatments that could be repurposed safely and effectively.
http://www.fromhopetocures.org/new-technologies-are-accelerating-drug-development-bringing-hope-to-patients

Cheering the Biosciences in West Virginia

PhRMA  |  Blog Post

"Bioscience products combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and use safer, more efficient industrial manufacturing processes.
http://catalyst.phrma.org/cheering-the-biosciences-in-west-virginia

PhRMA Statement on Supporting Safe Disposal Resources

PhRMA  |  Press Release

PhRMA recommends that all unused medicines, unless specified otherwise by the Food and Drug Administration, should be mixed with water; sealed in an opaque container safely secure from children, pets, and others; and discarded in household trash to be later incinerated or placed in a government approved solid waste landfill.
https://www.phrma.org/press-release/phrma-statement-on-supporting-safe-disposal-resources

PhRMA Challenges Unconstitutional Provisions of California’s SB 17 in Federal Court

PhRMA  |  Press Release

This law, therefore, expressly saddles the entire country with California’s misguided drug pricing policy by imposing restrictions on the national list price of manufacturers’ medicines.
https://www.phrma.org/press-release/phrma-challenges-unconstitutional-provisions-of-california-s-sb-17-in-federal-court

MyOldMeds campaign launches in Massachusetts

PhRMA  |  Blog Post

As Governor Baker said, “Too many lives are being lost in the Commonwealth as a result of the opioid epidemic, and opportunities to bring stakeholders together to build public awareness and encourage action are just one step we can take to curb this tragedy.
http://catalyst.phrma.org/myoldmeds-campaign-launches-in-massachusetts

How to get value assessment frameworks right

PhRMA  |  Blog Post

Read how value assessment frameworks fit within PhRMA’s pragmatic, patient-centric approaches to building a stronger U.S. health care market here.
http://catalyst.phrma.org/how-to-get-value-assessment-frameworks-right

Burden on Patients: 5 Questions on Access to HIV/AIDS Medicines in Health Exchange Plans

PhRMA  |  Blog Post

Our goal is to make sure people with HIV and hepatitis are given the proper care and treatment they need as well as prevent new infections.
http://catalyst.phrma.org/burden-on-patients-5-questions-on-access-to-hiv/aids-medicines-in-health-exchange-plans

Johnson & Johnson, Pfizer, Walgreens and other CEOs discuss value in the future of health care

PhRMA  |  Blog Post

Margolis professor of business, medicine and policy and director, Duke-Margolis Center for Health Policy at Duke University View past events of The Value Collaborative here.  
http://catalyst.phrma.org/janssen-pfizer-walgreens-and-other-ceos-discuss-value-in-the-future-of-health-care

New Report Shows Major Diseases Being Addressed With Over 230 Medicines in Development for Children

PhRMA  |  Press Release

In 2005, he helped lead the Steelers to a Super Bowl victory in his home town of Detroit.
https://www.phrma.org/press-release/new-report-shows-major-diseases-being-addressed-with-over-230-medicines-in-development-for-children

You have reviewed the first 450 results out of 1102. Each page contains 25 results. You're on page 18.

prev 13 14 15 16 17 18 next